Merck Provides Update on Phase 3 MOVe-AHEAD Trial Evaluating LAGEVRIO™ (molnupiravir) for Post-exposure Prophylaxis for Prevention of COVID-19
, Press Release (Preprint), NCT04939428 (history)
, Merck Provides Update on Phase 3 MOVe-AHEAD Trial Evaluating LAGEVRIO™ (molnupiravir) for Post-exposure.., , Press Release (Preprint), NCT04939428
MOVe-AHEAD PEP RCT reporting no significant difference in cases. Limited information is available. There were 23.6% fewer cases with treatment, but the number of cases and confidence interval are not provided.Concerns have been raised that the mutagenic mechanism of action may create dangerous variants or cause cancer [Hadj Hassine, Swanstrom]. See [Fountain-Jones, Sanderson, twitter.com] for analysis of variants potentially created by molnupiravir.
1.
Fountain-Jones et al., medRxiv, doi:10.1101/2022.12.21.22283811,
Antiviral treatments lead to the rapid accrual of hundreds of SARS-CoV-2 mutations in immunocompromised patients,
https://www.medrxiv.org/content/10.1101/2022.12.21.22283811.
2.
Hadj Hassine et al., Viruses, doi:10.3390/v14040841,
Lethal Mutagenesis of RNA Viruses and Approved Drugs with Antiviral Mutagenic Activity,
https://www.mdpi.com/1999-4915/14/4/841.
3.
Sanderson et al., medRxiv, doi:10.1101/2023.01.26.23284998,
Identification of a molnupiravir-associated mutational signature in SARS-CoV-2 sequencing databases,
https://www.medrxiv.org/content/10.1101/2023.01.26.23284998.
Merck et al., 21 Feb 2023, Double Blind Randomized Controlled Trial, multiple countries, preprint, 1 author, trial NCT04939428 (history).
Loading..
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation. FLCCC and WCH
provide treatment protocols.